Angiotensin receptor blockers (ARBs) and beta-blockers have similar and independent effects on reducing aortic root size in patients with Marfan syndrome, suggesting that several years of combined treatment could delay the ...
Aug 29, 2022
0
6
A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways ...
Aug 17, 2022
0
134
Researchers at McMaster University have found a class of well-known antiviral drugs could be part of a one-two punch to treat seasonal influenza and prevent a flu pandemic when used in combination with antibody therapies.
Aug 16, 2022
0
26
In a new study, researchers at Karolinska Institutet show that the activation of specific cell surface proteins—cortisol, estrogen and vitamin A—in mice with human neuroblastoma cells results in the neuronal differentiation ...
Jul 25, 2022
0
22
People with hematologic malignancies—or blood cancers including leukemia, lymphoma, and multiple myeloma—have an impaired immune system due to their disease and its treatment, putting them at risk of severe COVID-19 infection ...
Jul 11, 2022
0
3
A new combination therapy to combat cancer could one day consist of a plant virus and an antibody that activates the immune system's "natural killer" cells, shows a study by researchers at the University of California San ...
Jun 22, 2022
0
132
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumors.
Jun 16, 2022
0
5
Researchers from the University of Missouri School of Medicine have discovered a specific combination immunotherapy that shows promise in the fight against liver cancer.
May 18, 2022
0
7
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergized with radiotherapy can control nasopharyngeal carcinoma (NPC) by ...
May 18, 2022
0
9
Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model ...
Apr 27, 2022
0
27
